Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana

The ever-growing commercialization of poor-quality and substandard medicines, especially anti-infectives characterized by inadequate postmarket surveillance by stakeholders remains a major global health challenge, particularly in developing countries, where antibiotic drug resistance and its repercu...

Full description

Saved in:
Bibliographic Details
Main Authors: Christina Osei-Asare, Esther Eshun Oppong, Frederick William Akuffo Owusu, John Antwi Apenteng, Yvonne Ochesinda Alatu, Robert Sarpong
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2021/6659995
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559917322469376
author Christina Osei-Asare
Esther Eshun Oppong
Frederick William Akuffo Owusu
John Antwi Apenteng
Yvonne Ochesinda Alatu
Robert Sarpong
author_facet Christina Osei-Asare
Esther Eshun Oppong
Frederick William Akuffo Owusu
John Antwi Apenteng
Yvonne Ochesinda Alatu
Robert Sarpong
author_sort Christina Osei-Asare
collection DOAJ
description The ever-growing commercialization of poor-quality and substandard medicines, especially anti-infectives characterized by inadequate postmarket surveillance by stakeholders remains a major global health challenge, particularly in developing countries, where antibiotic drug resistance and its repercussions on human health remain dominant. This research sought to evaluate the pharmaceutical quality of six randomly selected brands of cefuroxime axetil tablets (250 mg) marketed in the Greater Accra region of Ghana. The selected brands were coded and subjected to both compendial and noncompendial tests. Statistical analysis and model-independent parameter (similarity factor, f2) were employed in analyzing the dissolution profiles of all the brands. All brands including the reference brand conformed to the pharmacopeial specifications for both compendial and noncompendial tests, indicating that they were of good quality. However, there were significant variations (p<0.05) in the disintegration time amongst the various brands. All the brands had ƒ2 values > 50 indicating similarity of their drug release profiles with the innovator. Hence, all the sampled cefuroxime axetil brands can be considered as pharmaceutical equivalents to the innovator drug. These brands can, therefore, be used as a substitute for the innovator drug by physicians to patients in cases of unaffordability or unavailability of the innovator brand.
format Article
id doaj-art-950b93cc80ef4bccaf72b9c8ce0538c9
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-950b93cc80ef4bccaf72b9c8ce0538c92025-02-03T01:28:52ZengWileyThe Scientific World Journal2356-61401537-744X2021-01-01202110.1155/2021/66599956659995Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of GhanaChristina Osei-Asare0Esther Eshun Oppong1Frederick William Akuffo Owusu2John Antwi Apenteng3Yvonne Ochesinda Alatu4Robert Sarpong5Department of Pharmaceutics, School of Pharmacy, Central University, Miotso, GhanaDepartment of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, University of Cape Coast, Cape Coast, GhanaDepartment of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, GhanaDepartment of Pharmaceutics, School of Pharmacy, Central University, Miotso, GhanaDepartment of Pharmaceutics, School of Pharmacy, Central University, Miotso, GhanaDepartment of Pharmaceutics, School of Pharmacy, Central University, Miotso, GhanaThe ever-growing commercialization of poor-quality and substandard medicines, especially anti-infectives characterized by inadequate postmarket surveillance by stakeholders remains a major global health challenge, particularly in developing countries, where antibiotic drug resistance and its repercussions on human health remain dominant. This research sought to evaluate the pharmaceutical quality of six randomly selected brands of cefuroxime axetil tablets (250 mg) marketed in the Greater Accra region of Ghana. The selected brands were coded and subjected to both compendial and noncompendial tests. Statistical analysis and model-independent parameter (similarity factor, f2) were employed in analyzing the dissolution profiles of all the brands. All brands including the reference brand conformed to the pharmacopeial specifications for both compendial and noncompendial tests, indicating that they were of good quality. However, there were significant variations (p<0.05) in the disintegration time amongst the various brands. All the brands had ƒ2 values > 50 indicating similarity of their drug release profiles with the innovator. Hence, all the sampled cefuroxime axetil brands can be considered as pharmaceutical equivalents to the innovator drug. These brands can, therefore, be used as a substitute for the innovator drug by physicians to patients in cases of unaffordability or unavailability of the innovator brand.http://dx.doi.org/10.1155/2021/6659995
spellingShingle Christina Osei-Asare
Esther Eshun Oppong
Frederick William Akuffo Owusu
John Antwi Apenteng
Yvonne Ochesinda Alatu
Robert Sarpong
Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
The Scientific World Journal
title Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
title_full Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
title_fullStr Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
title_full_unstemmed Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
title_short Comparative Quality Evaluation of Selected Brands of Cefuroxime Axetil Tablets Marketed in the Greater Accra Region of Ghana
title_sort comparative quality evaluation of selected brands of cefuroxime axetil tablets marketed in the greater accra region of ghana
url http://dx.doi.org/10.1155/2021/6659995
work_keys_str_mv AT christinaoseiasare comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana
AT esthereshunoppong comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana
AT frederickwilliamakuffoowusu comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana
AT johnantwiapenteng comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana
AT yvonneochesindaalatu comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana
AT robertsarpong comparativequalityevaluationofselectedbrandsofcefuroximeaxetiltabletsmarketedinthegreateraccraregionofghana